Dexamethasone as Treatment in Cerebrovascular Disease. 2. A Controlled Study in Acute Cerebral Infarction
Fifty-four patients with acute cerebral infarction were included in a double-blind study to evaluate Decadron® as therapy. When comparison of patients with similar levels of consciousness was made, there was no significant difference between those patients receiving Decadron® and those receiving placebo therapy.
Three patients developed gastrointestinal tract bleeding in the placebo group, but there were none in the Decadron®-treated group.
There was no good correlation between the clinical state of the patient and the CSF pressure, either on admission or during the 14-day course of the study.
- CSF pressures in cerebral Infarction
- Gl bleeding with use of steroids
- effect of steroids on CSF pressure
- © 1973 American Heart Association, Inc.